FDA Examines Testosterone Use in Menopausal Women
The FDA examined testosterone use in menopausal women, including current evidence, safety questions, research gaps and potential future drug development.
A Historic Win for Women: FDA Drops Black Box Warning from Menopausal Hormone Therapy
In a historic move, the FDA has requested the removal of the black box warning from hormone therapy used for menopause. Experts say this long-overdue update reflects modern science—and could help women reclaim access to safe, effective symptom relief.
New Research Finds Early Menopause Hormone Therapy May Offer Big Benefits with Lower Risks
A major 2024 review of the Women’s Health Initiative has rewritten the story on hormone therapy. For women under 60 or within 10 years of menopause, the benefits may outweigh the risks—marking a turning point in how doctors and patients approach treatment.
New Study Highlights Rising Cardiovascular Risk for Postmenopausal Women
A major study reveals women’s heart health declines rapidly after menopause, making this a crucial time for screening, prevention, and awareness.